The advances in early detection coupled with improvements in treatments have led to an ever-increasing number of breast cancer survivors. New methods to improve outcomes, including strategies aimed at improving the quality of life and reducing the risk of other diseases, may represent valid additions to the currently available treatment options. Interventions targeting diet, weight and physical activity can reduce the risk of cancer occurrence, prevent cancer recurrence, improve survival and the quality of life.
This is an observational, prospective study aimed at evaluating the effects of physical activity on the quality of life of patients with early stage hormone receptor positive breast cancer receiving adjuvant hormonal therapy and adhering to a physical activity program lasting for a total of 12 weeks organized by ANDOS onlus (Associazione Italiana Donne Operate al Seno).
Eligibility
Sex
FEMALE
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* Patients with early stage (I-IIIa) hormone receptor-positive breast cancer receiving adjuvant endocrine therapy
* Female patients ≥18 years of age
* Written informed consent must be obtained before any study-related assessment is performed
* Participation to the Medicina and Sport physical activity program organized by Andos Pordenone
Exclusion Criteria:
* Patients with early hormone receptor negative breast cancer
* Patients with early hormone receptor positive breast cancer receiving chemotherapy
* Patients with advanced/metastatic breast cancer.
* Patients receiving active treatment for secondary primary tumors (excluding basal cell carcinoma or in situ neoplasias).
* Patients with history of vertebral and/or femoral fractures
* Patients with CVDs not optimally controlled by medical therapy
Primary outcome measure(s)
Change in Quality of Life as measured by the EORTC QLQ-C30 questionnaire. — Up to 6 months after the end of the physical activity program Mean differences on the questionnaire will be evaluated. The EORTC QLQ-C30 (European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire) is a 30-item validated tool used to assess the physical, psychological, and social functions of cancer patients. Higher scores on functional scales and the global health status represent a higher/better level of functioning, while higher scores on symptom scales represent a higher level of symptomatology.
Trial sites (1)
Facility
City
Region
Status
Centro di Riferimento Oncologico di Aviano
Aviano
Pordenone
Recruiting
More Centro di Riferimento Oncologico - Aviano trials in Italy
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.
